İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

SOYKAN AĞAR

DOKTOR ÖĞRETİM ÜYESİ

KOCAELİ SAĞLIK VE TEKNOLOJİ ÜNİVERSİTESİ DİŞ HEKİMLİĞİ FAKÜLTESİ DİŞ HEKİMLİĞİ PR.

Araştırma konuları OpenAlex
Anahtar kelimeler YÖKSİS
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 34
YÖKSİS34 OpenAlex0
Proje 4
Kitap 0
Bildiri 11

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 27
h-indeks 7 Türkiye yüzdelik dilimi: 74 Üniversitesinde h-indekse göre 28. / 103
i10-indeks
6
Toplam atıf
228
Türkiye’de üst %22
Makale başına
8,4
FWCI
0,78
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
1

En çok atıf alan makaleleri

  1. An Emerging Post‐polymerization Modification Technique: The Promise Of Thiol‐para‐fluoro Click Reaction 2018 dünyada üst %10 87 atıf
  2. Elucidation Of Binding Interactions And Mechanism Of Fludarabine With Dsdna Via Multispectroscopic And Molecular Docking Studies 2020 28 atıf
  3. Voltammetric Quantification, Spectroscopic, And DFT Studies On The Binding Of The Antineoplastic Drug Azacitidine With DNA 2024 19 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 23
  • Q1 5
  • Q2 7
  • Q3 8
  • Q4 3
WoS (JCR) 19
  • Q1 4
  • Q2 6
  • Q3 6
  • Q4 3
TR Index TR Index

10 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 1
  • Ort. 56.4%
  • n 27
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 23

WoS (JCR)

  • YÖKSİS satırı 19

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

21 dergi
Scopus (SJR)
Q1 5 Q2 7 Q3 8 Q4 3
WoS (JCR)
Q1 4 Q2 6 Q3 6 Q4 3
TR Index
10 makale

Makale listesi

  1. 2026 In Silico De Novo Lead Discovery of Methoxylated Myricetin Derivatives Targeting VEGFR2 in Hepatocellular Carcinoma Medicinal Chemistry YÖKSİS SJR Q3 JCR Q3
  2. 2026 Transition Metal Coordination Controls DNA Groove Recognition and Regioselectivity in Oligohistidine Complexes Journal of Biomolecular Structure and Dynamics YÖKSİS SJR Q2 JCR Q3
  3. 2026 Suppressing liver cancer via the VEGFR1 receptor using de novo Ellagic Acid Derivatives and co-drugs: Comprehensive in silico biochemistry research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations Current Topics in Medicinal Chemistry YÖKSİS SJR Q3 JCR Q2
  4. 2026 Indomethacin as a multi-target anticancer agent via transmembrane receptor-mediated tumor suppression: the need for de novo drug derivatization CURRENT DRUG TARGETS YÖKSİS SJR Q2 JCR Q2
  5. 2026 The Indications and Effects of Ellagic Acid on Transmembrane Receptors in Cancer Types JOURNAL OF KOCAELI HEALTH AND TECHNOLOGY UNIVERSITY DOI 10.66163/jokohtu.1910788 YÖKSİS OpenAlex 31.0%
  6. 2026 Suppressing AI Deception in In Silico Drug Design and Molecular Docking JOURNAL OF KOCAELI HEALTH AND TECHNOLOGY UNIVERSITY DOI 10.66163/jokohtu.1911754 YÖKSİS OpenAlex 38.5%
  7. 2026 MindNexQua: An Autonomous Generative AI Framework for De Novo Drug Design and In Silico Molecular Docking Orchestration JOURNAL OF KOCAELI HEALTH AND TECHNOLOGY UNIVERSITY YÖKSİS
  8. 2026 Suppressing Breast Cancer Via 2KS1 Protein Using Biochemical De Novo Drug Design And Repurposing Of Valproic ACID Derivatives With Better Indications: Comprehensive Molecular Docking, Molecular Dynamics Simulations, 1H Nmr, And Admet Estimations ACTA MEDICA NICOMEDIA DOI 10.53446/actamednicomedia.1814887 YÖKSİS TR Index OpenAlex 16.4%
  9. 2026 INHIBITING LIVER CANCER VIA THE VEGFR1 RECEPTOR PROTEIN USING IN SILICO BIOCHEMISTRY DE NOVO DRUG ANALOGUES OF ELLAGIC ACID: COMPREHENSIVE ADMET, RMSD, MOLECULAR DOCKING, AND MOLECULAR DYNAMICS SIMULATIONS Kocaeli Üniversitesi Sağlık Bilimleri Dergisi DOI 10.30934/kusbed.1860724 YÖKSİS TR Index OpenAlex 50.9%
  10. 2026 The drug repurposing use of Amitriptyline as a VEGFR1 inhibitor: Liver Cancer Suppression via Comprehensive in silico Biochemistry, Molecular Docking, Molecular Dynamics Simulations and ADMET Acta Medica Nicomedia DOI https://dergipark.org.tr/tr/pub/actamednicomedia YÖKSİS TR Index
  11. 2025 Electrochemical Quantification Based On The Interactions Of Nucleoside Analog Cladribine With Dsdna Via Experimental And In-silico Studies. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES DOI 10.1016/j.ijbiomac.2024.138083 YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.8%
  12. 2025 An In-Depth Study of Clofarabine's Binding Mechanism to DNA: A Thorough Experimental and Theoretical Investigation COMPUTATIONAL BIOLOGY AND CHEMISTRY DOI 10.1016/j.compbiolchem.2025.108418 YÖKSİS SJR Q2 JCR Q1 OpenAlex 77.4%
  13. 2025 Investigating The Interactions Of Axitinib, A Tyrosine Kinase Inhibitor, With DNA: Experimental Studies, Molecular Docking, And Molecular Dynamics Simulations NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS DOI 10.1080/15257770.2025.2509977 YÖKSİS SJR Q3 JCR Q4 OpenAlex 72.5%
  14. 2025 Inhibition Of Pancreatic Cancer Via Lpar4 Receptor With A De Novo Drug Complex Design Using Organic Chemistry: Comprehensive Molecular Docking, Molecular Dynamics JOURNAL OF RESEARCH IN PHARMACY (ONLINE) DOI 10.29228/jrp.785 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 64.6%
  15. 2025 Shaping the Future of University Education: The Role of Artificial Intelligence in Higher Education and Its Impact on Foreign Language and Chemistry Courses within Health Sciences Faculties AMERICAN JOURNAL OF EDUCATIONAL RESEARCH DOI 10.12691/education-13-3-2 YÖKSİS OpenAlex 4.5%
  16. 2025 In Silico Biochemical De Novo Drug Design Of Valproic ACID Derivatives To Suppress Cancerous DNA: Comprehensive Molecular Docking, Molecular Dynamics, 1H NMR, Adme ACTA MEDICA NICOMEDIA DOI 10.53446/actamednicomedia.1814797 YÖKSİS TR Index OpenAlex 13.9%
  17. 2024 De Novo Drug Design And Repurposing To Suppress Liver Cancer via VEGF-R1 Mechanism: Comprehensive Molecular Docking, MolecularDynamics Simulations And ADME Estimation MEDICINAL CHEMISTRY DOI 10.2174/0115734064333811240928105309 YÖKSİS SJR Q3 JCR Q3 OpenAlex 77.9%
  18. 2024 Voltammetric Quantification, Spectroscopic, And DFT Studies On The Binding Of The Antineoplastic Drug Azacitidine With DNA JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS DOI 10.1016/j.jpba.2023.115746 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.6%
  19. 2024 High Performance Liquid Chromatography-Tandem Mass Spectrometric determination of carcinogen nitrosamine impurities from pharmaceuticals and DNA binding confirmation aided by molecular docking application. ISTANBUL JOURNAL OF PHARMACY DOI 10.26650/IstanbulJPharm.2024.1500047 YÖKSİS TR Index OpenAlex 62.1%
  20. 2024 In Silico Drug Repurposing of Nerol in the Inhibition of Cancerous DNA Medicres AI DOI https://www.medicres.ai/_files/ugd/8d8849_72636ab64efb457c81e9dc05ddea0d22.pdf YÖKSİS

Akademisyenlere dön